Response to cytostatic treatment in inoperable adenocarcinoma of the lung: Clinical implicationsJakob B. Sørensen(University of Copenhagen), H.H. Hansen, J.H. BadsbergEuropean Journal of Cancer and Clinical OncologySeptember 1, 198810.1016/0277-5379(88)90363-xCited by 0SaveCiteExport RISWatch citationsRelated PapersDifferential Control of the Releasable Vesicle Pools by SNAP-25 Splice Variants and SNAP-23|Cell|2003|369Fast Vesicle Fusion in Living Cells Requires at Least Three SNARE Complexes|Science|2010|331Sequential N‐ to C‐terminal SNARE complex assembly drives priming and fusion of secretory vesicles|The EMBO Journal|2006|310Synaptotagmin-1 Docks Secretory Vesicles to Syntaxin-1/SNAP-25 Acceptor Complexes|Cell|2009|269Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck|Annals of Oncology|1994|259